Sign in

CIK 0001819576

  • Non-accelerated filer

Liquidia Corp

Sign in to watch
Ticker
LQDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
851710962
Phone
+1 919-328-4400
Business address
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC, 27560
  1. 4 Planned sale Chief Business Officer sold 454 shares at $19.54 ($8,871)
  2. 4 Planned sale Chief Accounting Officer sold 1,063 shares at $19.54 ($20,771)
  3. 4 Planned sale Chief Medical Officer sold 2,526 shares at $14.54 ($36,728)
  4. 4 Planned sale General Counsel sold 7,836 shares at $14.28 ($111,898)
  5. 4 Planned sale Chief Medical Officer sold 5,327 shares at $14.28 ($76,070)
  6. 4 Planned sale Chief Commercial Officer sold 4,797 shares at $14.28 ($68,501)
  7. 4 Planned sale Chief Human Resource Officer sold 2,673 shares at $14.28 ($38,170)
  8. 4 Planned sale CFO and COO sold 11,580 shares at $14.28 ($165,362)
  9. 4 Planned sale Chief Executive Officer sold 20,252 shares at $14.28 ($289,199)
  10. 4 Planned sale Chief Executive Officer sold 20,252 shares at $14.28 ($289,199)
  11. 4 Planned sale Chief Accounting Officer sold 1,193 shares at $14.28 ($17,036)
  12. 4 Planned sale Chief Business Officer sold 2,576 shares at $14.28 ($36,785)
  13. 4 Grant or award Chief Human Resource Officer acquired 25,000 shares (grant or award)
  14. 4 Grant or award Chief Accounting Officer acquired 25,000 shares (grant or award)
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 4 Grant or award Director acquired 18,396 shares (grant or award)
  18. 4 Grant or award Director acquired 18,396 shares (grant or award)
  19. 4 Grant or award Director acquired 18,396 shares (grant or award)
  20. 4 Grant or award Director acquired 18,396 shares (grant or award)

Page 8 of 21 · 410 filings